Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

11.72 +0.17 (+1.52%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	10,492,237
Open	10.91
Bid (Size)	11.69 (2,300)
Ask (Size)	11.80 (300)
Prev. Close	11.55
Today's Range	10.78 - 12.28
52wk Range	1.390 - 15.88
Shares Outstanding	15,873,941
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Get insights into the top gainers and losers of Monday's pre-market session. ↗

Today 8:30 EDT

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 08, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	+169.5%	+169.5%
1 Month	-8.3%	-8.3%
3 Month	+51.7%	+51.7%
6 Month	+118.7%	+118.7%
1 Year	+597.9%	+597.9%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 01, 2026

From Pomerantz LLP

Via GlobeNewswire

SELLAS Stock Hits New Highs: What's Happening Today? ↗

June 26, 2026

Via Benzinga

SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗

January 09, 2026

Via Stocktwits

Stay updated with the stocks that are on the move in today's pre-market session. ↗

May 13, 2026

Via Chartmill

These stocks are moving in today's after hours session ↗

May 12, 2026

Via Chartmill

SLS Stock Jumps Overnight: ‘Potent’ AML Drug Data Ahead Of Cancer Summit Fuels Fresh Momentum ↗

March 18, 2026

Via Stocktwits

SLS Stock In Spotlight: First AML Patient Enrolled In Phase 2 Leukemia Trial ↗

March 12, 2026

Via Stocktwits

SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail ↗

March 09, 2026

Via Stocktwits

Dow, S&P 500, Nasdaq Futures Dip After Wall Street Rebound: Why SLS, ZVRA, RLMD, USO, CASY Are Trending After-Hours ↗

March 09, 2026

Via Stocktwits

SLS Stock Falls Premarket: CEO Touts GPS Leukemia Strategy, But Investors Stay Cautious As AML Trial Nears Readout ↗

March 09, 2026

Via Stocktwits

SLS Stock Takes A Breather After Big Run: Traders Eye AML Summit Featuring Advisor For Clues On Trial Readout ↗

March 06, 2026

Via Stocktwits

SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout ↗

March 05, 2026

Via Stocktwits

SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside ↗

March 04, 2026

Via Stocktwits

SLS Stokes Retail Anticipation For Breakout Rally — What’s Driving The Interest? ↗

February 27, 2026

Via Stocktwits

Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% ↗

February 23, 2026

Via Stocktwits

SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout ↗

January 14, 2026

Via Stocktwits

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

January 08, 2026

From Equity Insider

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗

January 06, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

January 06, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗

January 06, 2026

Via Stocktwits

SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B ↗

January 05, 2026

Via Stocktwits

Why Is SLS Stock Drawing Significant Investor Attention Today? ↗

December 31, 2025

Via Stocktwits

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

Via MarketMinute

Frequently Asked Questions

Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?

Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.

What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?

SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?

The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market

What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?

The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 11.72

When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?

The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 09/14/26 04:00 PM ET

What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?

The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 186.12M

How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?

SELLAS Life Sciences Group, Inc. - Common Stock has 186M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.